Minipress (Prazosin)

Medication Information & Treatment Considerations

Minipress (prazosin) is a prescription medication that may be considered by a licensed psychiatric provider as part of a treatment plan when clinically appropriate. Treatment recommendations are based on an individual’s symptoms, medical history, treatment goals, and overall clinical evaluation. Prazosin works by blocking alpha-1 adrenergic receptors, which are involved in the body’s response to stress and adrenaline. Individual experiences with medication vary, and treatment outcomes depend on many factors unique to each person. Minipress is not a controlled substance and must be prescribed by a licensed psychiatric provider. Through Telemynd, medication may be prescribed following a secure virtual evaluation when clinically appropriate. Many insurance plans cover prazosin, and generic options are widely available. Some people may experience side effects such as dizziness, fatigue, headache, low blood pressure, or lightheadedness, particularly when starting treatment or adjusting dosage. Your provider will monitor your response to treatment and make adjustments as needed.

Important Safety Information

Minipress may lower blood pressure and can cause dizziness, lightheadedness, or fainting, particularly when standing up quickly or when treatment is first started. This medication may affect alertness in some individuals and may not be appropriate for everyone. Before starting or changing any medication, discuss potential risks, benefits, side effects, warnings, and drug interactions with your healthcare provider. For complete prescribing information, medication warnings, precautions, contraindications, drug interactions, and the FDA-approved Medication Guide, please review the current FDA-approved prescribing information for Minipress (prazosin).

Educational Notice

This content is provided for informational and educational purposes only and should not be considered medical advice, treatment recommendations, or a guarantee that any medication will be prescribed. Medication decisions are made by licensed healthcare providers following a comprehensive clinical evaluation and consideration of individual needs.

Last reviewed: June 2026. Prescribing information may change. Refer to the current FDA-approved labeling for the most up-to-date safety information.